Literature DB >> 29707916

Association between Parathyroid Hormone and Cardiovascular Disease.

Hideki Fujii1.   

Abstract

Although parathyroid hormone is known to be related with calcium and phosphate metabolism, it has been also reported to have several effects on the cardiovascular system including heart and vessels. However, the detailed pathophysiological mechanisms remain unclear. Clinical studies have indicated that parathyroid hormone is associated with cardiovascular events and mortality not only in patients with chronic kidney disease but also in those without chronic kidney disease. As a possible mechanism, it is thought that parathyroid hormone is associated with the renin-angiotensin-aldosterone system and has direct effects on the cardiovascular system. Therefore, we should pay attention to not only the control of serum phosphate and calcium levels but also the control of serum parathyroid hormone levels, especially in patients with chronic kidney disease.
© 2018 The Authors. Therapeutic Apheresis and Dialysis published by John Wiley & Sons Australia, Ltd on behalf of International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy.

Entities:  

Keywords:  Aldosterone; Cardiovascular Disease; Chronic Kidney Disease; Parathyroid Hormone; Renin-angiotensin-Aldosterone System

Mesh:

Substances:

Year:  2018        PMID: 29707916     DOI: 10.1111/1744-9987.12679

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  9 in total

Review 1.  Role of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disorders.

Authors:  Natalia Carrillo-López; Laura Martínez-Arias; Jorge B Cannata-Andía; Manuel Naves-Díaz; Sara Panizo; Sara Fernández-Villabrille; María Piedad Ruiz-Torres; Adriana Dusso
Journal:  Calcif Tissue Int       Date:  2021-02-13       Impact factor: 4.333

2.  Global longitudinal strain is superior to ejection fraction for detecting myocardial dysfunction in end-stage renal disease with hyperparathyroidism.

Authors:  Maria Fernanda Carrasco-Ruiz; Antonio Ruiz-Rivera; Marvin A Soriano-Ursúa; Carlos Martinez-Hernandez; Leticia Manuel-Apolinar; Carmen Castillo-Hernandez; Gustavo Guevara-Balcazar; Eunice D Farfán-García; Ana Mejia-Ruiz; Ivan Rubio-Gayosso; Teresa Perez-Capistran
Journal:  World J Cardiol       Date:  2022-04-26

3.  Relationship between parathyroid hormone and renin-angiotensin-aldosterone system in hemodialysis patients with secondary hyperparathyroidism.

Authors:  Keiji Kono; Hideki Fujii; Kentaro Watanabe; Shunsuke Goto; Shinichi Nishi
Journal:  J Bone Miner Metab       Date:  2020-09-12       Impact factor: 2.626

4.  Serum sirtuin 1 is independently associated with intact PTH among patients with chronic kidney disease.

Authors:  Angelika Bielach-Bazyluk; Edyta Zbroch; Katarzyna Czajkowska; Ewa Koc-Zorawska; Katarzyna Kakareko; Alicja Rydzewska-Rosolowska; Tomasz Hryszko
Journal:  Clin Interv Aging       Date:  2021-03-25       Impact factor: 4.458

5.  Clinical progression of cats with early-stage chronic kidney disease fed diets with varying protein and phosphorus contents and calcium to phosphorus ratios.

Authors:  Sofia Schauf; Jennifer C Coltherd; Jujhar Atwal; Matthew Gilham; Laura J Carvell-Miller; Helen Renfrew; Jonathan Elliott; Denise Elliott; Esther S Bijsmans; Vincent C Biourge; Phillip Watson; Anne Marie Bakke
Journal:  J Vet Intern Med       Date:  2021-09-21       Impact factor: 3.333

6.  Parathyroid Hormone Induces Human Valvular Endothelial Cells Dysfunction That Impacts the Osteogenic Phenotype of Valvular Interstitial Cells.

Authors:  Mihaela Vadana; Sergiu Cecoltan; Letitia Ciortan; Razvan D Macarie; Andreea C Mihaila; Monica M Tucureanu; Ana-Maria Gan; Maya Simionescu; Ileana Manduteanu; Ionel Droc; Elena Butoi
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

7.  Association of Post Transplantation Anaemia and Persistent Secondary Hyperparathyroidism with Diastolic Function in Stable Kidney Transplant Recipients.

Authors:  Hon-Chun Hsu; Gavin R Norton; Ferande Peters; Chanel Robinson; Noluntu Dlongolo; Ahmed Solomon; Gloria Teckie; Angela J Woodiwiss; Patrick H Dessein
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-07-02

8.  Biological variation of metabolic cardiovascular risk factors in haemodialysis patients and healthy individuals.

Authors:  Zoraida Corte; Rafael Venta
Journal:  Ann Transl Med       Date:  2020-03

9.  Changes in 3-month mineral and bone disorder patterns were associated with all-cause mortality in prevalent hemodialysis patients with secondary hyperparathyroidism.

Authors:  Chihiro Kato; Naohiko Fujii; Chisato Miyakoshi; Shinji Asada; Yoshihiro Onishi; Shingo Fukuma; Takanobu Nomura; Michihito Wada; Masafumi Fukagawa; Shunichi Fukuhara; Tadao Akizawa
Journal:  BMC Nephrol       Date:  2020-10-12       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.